ATE428786T1 - Antisense-oligonukleotid mit antikrebsaktivität - Google Patents

Antisense-oligonukleotid mit antikrebsaktivität

Info

Publication number
ATE428786T1
ATE428786T1 AT04793044T AT04793044T ATE428786T1 AT E428786 T1 ATE428786 T1 AT E428786T1 AT 04793044 T AT04793044 T AT 04793044T AT 04793044 T AT04793044 T AT 04793044T AT E428786 T1 ATE428786 T1 AT E428786T1
Authority
AT
Austria
Prior art keywords
antisense oligonucleotide
cancer
therapeutic
cancer activity
inhibitor
Prior art date
Application number
AT04793044T
Other languages
English (en)
Inventor
Katsutomo Hamada
Original Assignee
Good Will Okinawa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Good Will Okinawa Co Ltd filed Critical Good Will Okinawa Co Ltd
Application granted granted Critical
Publication of ATE428786T1 publication Critical patent/ATE428786T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04793044T 2004-01-22 2004-10-27 Antisense-oligonukleotid mit antikrebsaktivität ATE428786T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004014883 2004-01-22
PCT/JP2004/015932 WO2005071082A1 (ja) 2004-01-22 2004-10-27 抗癌作用を有するアンチセンスオリゴヌクレオチド

Publications (1)

Publication Number Publication Date
ATE428786T1 true ATE428786T1 (de) 2009-05-15

Family

ID=34805433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04793044T ATE428786T1 (de) 2004-01-22 2004-10-27 Antisense-oligonukleotid mit antikrebsaktivität

Country Status (7)

Country Link
US (1) US7393951B2 (de)
EP (1) EP1707630B1 (de)
JP (1) JP4226006B2 (de)
CN (1) CN1816626B (de)
AT (1) ATE428786T1 (de)
DE (1) DE602004020677D1 (de)
WO (1) WO2005071082A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007035962A2 (en) * 2005-09-23 2007-03-29 California Institute Of Technology Gene blocking method
CN109517894B (zh) * 2018-08-31 2020-01-21 清华大学 一种与肝癌相关的非编码rna生物标志物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008003A1 (en) 1991-06-14 1994-04-14 Isis Pharmaceuticals, Inc. ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE
US5985558A (en) * 1997-04-14 1999-11-16 Isis Pharmaceuticals Inc. Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
EP0914326A1 (de) * 1996-03-22 1999-05-12 South Alabama Medical Science Foundation Molekul und verfahren um dns in einen kern einzufuhren
US6130207A (en) * 1997-11-05 2000-10-10 South Alabama Medical Science Foundation Cell-specific molecule and method for importing DNA into a nucleus
KR20010040448A (ko) * 1998-01-30 2001-05-15 진센스 테크놀로지즈 인코포레이티드 티오레독신 또는 티오레독신 환원효소의 유전자와상보적인 올리고뉴클레오 타이드 서열 및 이들을 사용하는세포성장 조절 방법
WO2002044332A2 (en) 2000-12-01 2002-06-06 Origene Technologies Inc Prostate polynucleotides and uses
US20030232443A1 (en) * 2002-06-18 2003-12-18 Isis Pharmaceuticals Inc. Antisense modulation of centromere protein B expression

Also Published As

Publication number Publication date
CN1816626A (zh) 2006-08-09
JPWO2005071082A1 (ja) 2007-12-27
EP1707630A4 (de) 2007-01-24
DE602004020677D1 (de) 2009-05-28
EP1707630A1 (de) 2006-10-04
US7393951B2 (en) 2008-07-01
EP1707630B1 (de) 2009-04-15
US20070129318A1 (en) 2007-06-07
CN1816626B (zh) 2010-05-26
WO2005071082A1 (ja) 2005-08-04
JP4226006B2 (ja) 2009-02-18

Similar Documents

Publication Publication Date Title
EP1490489A4 (de) Verfahren und mittel zur überwachung und modulation des gen-silencing
WO2007005645A3 (en) Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
WO2006018836A3 (en) Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
WO2010048552A3 (en) Methods of using oligomeric compounds comprising 2'-substituted nucleosides
DK2092065T4 (da) Antisense-forbindelser
WO2007076423A3 (en) INHIBITORS OF Akt ACTIVITY
EP1931806A4 (de) Pkr-aktivierung mittels hybridisierungskettenreaktion
EP2527444A3 (de) Antisense-Oligonukleotid-Modulation einer STAT3-Expression
WO2003097794A3 (en) Universal-tagged oligonucleotide primers and methods of use
EP1445312A4 (de) Verfahren zur hemmung der genexpression
WO2005089287A3 (en) Methods and compositions for the specific inhibition of gene expression by double-stranded rna
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
WO2005105829A3 (en) Caspase-2 inhibitors and their biological applications
WO2004080418A3 (en) Nucleic acid compounds for inhibiting angiogenesis and tumor growth
TW200716110A (en) Inhibitors of AKT activity
AU2005273867A1 (en) Benzothienopyridines for use as inhibitors of Eg5 kinesin
HK1106171A1 (en) Tetrahydropyridothiophenes
WO2006029161A3 (en) Cell specific gene silencing using cell-specific promoters in vitro and in vivo
WO2005118592A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
EP2157182A3 (de) Modifizierte kurz interferierende RNA
WO2005001039A3 (en) Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof
WO2004027056A3 (en) Methods of use for thermostable rna ligases
WO2005000320A3 (en) Use of double-stranded ribonucleic acid for inducing cell lysis
EP1546180A4 (de) Verwendung von antisens-oligonukleotiden zur inhibierung der expression von akt-1
BRPI0308119A2 (pt) microorganismo como portadores de seqüências de nucleotídeos codificando para antígenos de células para o tratamento de tumores.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties